HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 15, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	310,010	235,973	127,792	207,570	92,964	160,691
Market Cap Growth	169.73%	84.65%	-38.43%	123.28%	-42.15%	-29.01%
Enterprise Value	345,351	268,360	153,787	241,607	132,643	187,080
Last Close Price	22650.00	18170.00	9840.00	17930.00	9610.00	16050.00
PE Ratio	-	-	-	-	15.12	-
Forward PE	27.76	6.95	6.95	6.95	6.95	6.95
PS Ratio	3.45	2.63	1.58	2.66	1.25	2.72
PB Ratio	9.15	6.96	1.90	4.16	1.96	3.38
P/TBV Ratio	9.35	7.11	1.93	4.29	2.08	3.70
P/OCF Ratio	973.84	741.27	72.67	-	-	-
EV/Sales Ratio	3.85	2.99	1.90	3.10	1.78	3.17
EV/EBITDA Ratio	-	-	25.58	231.57	21.54	-
EV/EBIT Ratio	-	-	245.82	-	105.60	-
EV/FCF Ratio	-223.69	-	-	-	-	-
Debt / Equity Ratio	1.28	1.28	0.54	0.82	1.18	1.08
Debt / EBITDA Ratio	-	-	6.06	39.43	9.08	-
Asset Turnover	0.72	0.72	0.67	0.61	0.57	0.45
Inventory Turnover	1.34	1.34	1.05	1.20	1.26	1.64
Quick Ratio	0.31	0.31	0.38	0.31	0.32	0.49
Current Ratio	0.69	0.69	0.99	0.77	0.73	0.84
Return on Equity (ROE)	-63.51%	-63.51%	-13.33%	-49.47%	10.36%	-37.86%
Return on Assets (ROA)	-14.05%	-14.05%	0.32%	-2.04%	0.60%	-9.46%
Return on Invested Capital (ROIC)	-19.29%	-19.29%	0.40%	-2.67%	0.78%	-12.28%
Return on Capital Employed (ROCE)	-61.50%	-61.50%	0.90%	-7.30%	2.20%	-28.90%
Earnings Yield	-10.11%	-13.28%	-5.65%	-11.10%	6.61%	-11.38%
FCF Yield	-0.50%	-0.65%	-0.65%	-2.73%	-8.88%	-12.16%
Buyback Yield / Dilution	-0.29%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%
Total Shareholder Return	-0.29%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.